Navigation Links
Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million
Date:8/19/2007

1,853,070

Long-term liabilities, less current portion:

Unsecured loans payable 1,510,078 1,472,717

Bank notes payable - 1,351

Long-term convertible notes payable 2,171,401 2,365,962

Discount relating to warrants issued

with long-term convertible notes (1,066,342) (1,371,446)

Total long-term liabilities 2,615,137 2,468,584

Minority interest in a subsidiary 95,292 103,362

Shareholders' equity (deficiency)

Common stock - $0.001 par value

Authorized 200,000,000 shares at

June 30, 2007 and December 31, 2006

respectively. Issued and outstanding

75,120,710 and 70,149,556 shares at

June 30, 2007 and December 31, 2006,

respectively 75,121 70,150

Preferred stock - $0.001 par value

Authorized 20,000,000 shares, nil

shares issued and outstanding

at June 30, 2007 and December

31, 2006, respectively - -

Additional paid-in capital 8,714,848 8,311,975

Stock-based compensation reserve (389,342) (523,468)

Deficit Accumulated (9,712,807) (7,766,654)

Accumulated other comprehensive income 3,632 1,166

Total shareholders' equity (deficiency) (1,308,548) 93,169

Total liabilities and stockholders'

equity $3,627,740 $4,518,185


'/>"/>
SOURCE Kiwa Bio-Tech Products Group Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related biology technology :

1. Industry Veterans take a look back from 2025: Bio-Technology, and Bio-Informatics are the focus
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports stronger earnings and revenues
4. Third Waves revenues rebound
5. Electronic signs for municipalities: Las Vegas or lost revenues?
6. TDS restates years of revenues, shows slight profit drop
7. Standard Networks reports 125% growth in software revenues
8. Catalyst International profit exceeds expectations
9. New report says Wisconsin R&D spending exceeding expectations
10. Submissions to the Gov.s Business Plan Contest Exceed Expectations
11. Venture Investors early-stage fund grows to $115 million
Post Your Comments:
*Name:
*Comment:
*Email: